Pfizer announced that it’s in its phase two clinical trials of a daily pill taken orally to combat COVID-19. The company’s CEO, Albert Bourla, wrote on Twitter that to beat the virus, it will “likely require both vaccines [and] treatments.” And in other news, the Taliban has declared that China is its “main partner” and hinted at future infrastructure programs under the Taliban–China partnership.
In this live Q&A with Crossroads host Joshua Philipp, we’ll discuss these stories and others, and answer questions from the audience.
We’re being heavily censored by Big Tech. Our solution? Create our own independent platform free of censorship.
Follow EpochTV on social media: